Evidence map›Paper›PMID 37113183›Full record

ArticleFrontiers in public health2023

Lag-time effects of vaccination on SARS-CoV-2 dynamics in German hospitals and intensive-care units.

Bruno Enagnon Lokonon, Yvette Montcho, Paul Klingler, Chénangnon Frédéric Tovissodé, Romain Glèlè Kakaï, Martin Wolkewitz

Abstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Implementation evaluation of the COVID-19 vaccination: Speed, equity and mortality trends.African journal of primary health care & family medicine · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bruno Enagnon LokononLaboratoire de Biomathématiques et d'Estimations Forestières, Université d'Abomey-Calavi, Cotonou, Benin.
Yvette MontchoLaboratoire de Biomathématiques et d'Estimations Forestières, Université d'Abomey-Calavi, Cotonou, Benin.
Paul KlinglerFaculty of Medicine and Medical Center, Institute of Medical Biometry and Statistics, University of Freiburg, Freiburg im Breisgau, Germany.
Chénangnon Frédéric TovissodéLaboratoire de Biomathématiques et d'Estimations Forestières, Université d'Abomey-Calavi, Cotonou, Benin.
Romain Glèlè KakaïLaboratoire de Biomathématiques et d'Estimations Forestières, Université d'Abomey-Calavi, Cotonou, Benin.
Martin WolkewitzFaculty of Medicine and Medical Center, Institute of Medical Biometry and Statistics, University of Freiburg, Freiburg im Breisgau, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Efficacy and effectiveness of vaccination against SARS-CoV-2 have clearly been shown by randomized trials and observational studies. Despite these successes on the individual level, vaccination of the population is essential to relieving hospitals and intensive care units. In this context, understanding the effects of vaccination and its lag-time on the population-level dynamics becomes necessary to adapt the vaccination campaigns and prepare for future pandemics. Methods: This work applied a quasi-Poisson regression with a distributed lag linear model on German data from a scientific data platform to quantify the effects of vaccination and its lag times on the number of hospital and intensive care patients, adjusting for the influences of non-pharmaceutical interventions and their time trends. We separately evaluated the effects of the first, second and third doses administered in Germany. Results: The results revealed a decrease in the number of hospital and intensive care patients for high vaccine coverage. The vaccination provides a significant protective effect when at least approximately 40% of people are vaccinated, whatever the dose considered. We also found a time-delayed effect of the vaccination. Indeed, the effect on the number of hospital patients is immediate for the first and second doses while for the third dose about 15 days are necessary to have a strong protective effect. Concerning the effect on the number of intensive care patients, a significant protective response was obtained after a lag time of about 15-20 days for the three doses. However, complex time trends, e.g. due to new variants, which are independent of vaccination make the detection of these findings challenging. Conclusion: Our results provide additional information about the protective effects of vaccines against SARS-CoV-2; they are in line with previous findings and complement the individual-level evidence of clinical trials. Findings from this work could help public health authorities efficiently direct their actions against SARS-CoV-2 and be well-prepared for future pandemics.

Indexed as

COVID-19SARS-CoV-2COVID-19 VaccinesHospitalsHumansIntensive Care UnitsVaccinationCOVID-19 VaccinesCOVID-19delayed effectslinear lag modelsnon-pharmaceutical interventions (NPIs)policy decisionsvaccination

Identifiers

PMID37113183
PMCPMC10126254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.